Related Experiment Video
Updated: Jan 31, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research
1Department of Hematology-Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Abstract:
The best-known inherited mild bleeding disorders (MBDs), i.e. type 1 von Willebrand disease (VWD), platelet function disorders (PFDs), and mild to moderate clotting factor deficiencies, are characterized clinically by mucocutaneous bleeding, and, although they are highly prevalent, still pose difficult diagnostic problems. These include establishing the pathological nature of bleeding, and the uncertainties surrounding the clinical relevance of laboratory results. Furthermore, the high frequency of bleeding symptoms in the normal population and the subjective appraisal of symptoms by patients or parents makes elucidating the pathological nature of bleeding difficult. Standardized bleeding assessment tools and semiquantitative bleeding scores (BSs) help to discriminate normal from abnormal bleeding. However, as most MBDs have similar bleeding patterns, for example, bleeding sites, frequency, and severity, BSs are of little help for diagnosing specific diseases. Global tests of primary hemostasis (bleeding time; PFA-100/200) lack sensitivity and, like BSs, are not disease-specific. Problems with the diagnosis of type 1 VWD and PFD include assay standardization, uncertain definition of von Willebrand factor cut-off levels, and the lack of universal diagnostic criteria for PFD. Regarding clotting factor deficiencies, the bleeding thresholds of some coagulation factors, such as factor VII and FXI, are highly variable, and may lead to misinterpretation of the clinical relevance of mild to moderate deficiencies. Remarkably, a large proportion of MBDs remain undiagnosed even after comprehensive and repeated laboratory testing. These are tentatively considered to represent bleeding of undefined cause, with clinical features indistinguishable from those of classical MBD; the pathogenesis of this is probably multifactorial, and unveiling these mechanisms should constitute a fertile source of translational research.
Insights
Diagnosing mild bleeding disorders (MBDs) like von Willebrand disease and platelet function disorders is challenging due to overlapping symptoms and diagnostic uncertainties. Many MBDs remain undiagnosed, highlighting the need for further research into their causes.
Area of Science:
- Hematology
- Clinical Diagnostics
- Translational Research
Background:
- Inherited mild bleeding disorders (MBDs), including type 1 von Willebrand disease (VWD), platelet function disorders (PFDs), and mild clotting factor deficiencies, are prevalent but difficult to diagnose.
- Clinical presentation of mucocutaneous bleeding is common, but distinguishing pathological bleeding from normal variation is complicated by subjective symptom reporting and high prevalence in the general population.
Purpose of the Study:
- To review the diagnostic challenges associated with inherited mild bleeding disorders.
- To highlight the limitations of current diagnostic tools and identify areas for future research.
Main Methods:
- Review of diagnostic challenges in MBDs.
- Analysis of limitations of bleeding assessment tools (BSs) and global primary hemostasis tests (e.g., PFA-100/200).
- Discussion of diagnostic issues in type 1 VWD, PFDs, and clotting factor deficiencies.
Main Results:
- Standardized bleeding scores and global primary hemostasis tests lack specificity and disease-specific diagnostic utility for MBDs.
- Diagnostic difficulties persist for type 1 VWD and PFDs due to issues with assay standardization, defining cut-off levels, and universal criteria.
- Mild to moderate clotting factor deficiencies can be misinterpreted due to variable bleeding thresholds, leading to a significant proportion of MBDs remaining undiagnosed.
Conclusions:
- Current diagnostic approaches for MBDs are insufficient, leading to a substantial number of undiagnosed cases.
- Bleeding of undefined cause, clinically similar to classical MBDs, likely has multifactorial pathogenesis requiring further investigation.
- Unraveling the mechanisms of undiagnosed MBDs presents a promising avenue for translational research.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Chromosomal Theory of Inheritance

